| 产品详情 |
| Edit |   |
|---|
| Product Name | QNZ 46 |
|---|
| Description | Purity >98%. QNZ 46 is an antagonist of NR2C- and NR2D-subunit containing NMDA receptors (IC50 s = 6 and 3 µM, respectively, for receptors expressed in Xenopus oocytes). It is selective for NR2C- and NR2D-subunit containing NMDA receptors over receptors containing NR2A and NR2B subunits as well as over the AMPA receptor GluR1 (IC50 s = 229, >300, and >300 µM, respectively). QNZ 46 acts in a noncompetitive and voltage-independent fashion that requires glutamate but not glycine binding for its activity. |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 4-[6-methoxy-2-[(1E)-2-(3-nitrophenyl)ethenyl]-4-oxo-3(4H)-quinazolinyl]-benzoic acid |
|---|
| Gene, Accession, CAS # | CAS: 1237744-13-6 |
|---|
| Catalog # | LS-H9618 |
|---|
| Price | |
|---|
| Order / More Info | QNZ 46 from LIFESPAN BIOSCIENCES INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|